Vaccination

Why paying people to get the coronavirus vaccine won't work

The first COVID-19 vaccine to gain emergency use authorization in the U.S. could roll out within days, as Pfizer and BioNTech's candidate was endorsed by an external advisory panel to the Food and Drug Administration on Dec. ...

Diseases, Conditions, Syndromes

Study tracks public concerns on Twitter about COVID-19

Twitter users initially didn't feel positive about the state of the economy, prevention, treatment and recovery concerning COVID-19. That changed by the end of March 2020. In contrast, throughout the period examined from ...

Medical economics

COVID-19 vaccine nationalism could cost world up to $1.2 trillion

Nationalistic behavior by governments may exclude some countries from gaining access to COVID-19 vaccines and cost the global economy up to $1.2 trillion a year in GDP, according to a new study from the not-for-profit research ...

page 8 from 26